ArticleCancers2024

Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET

Margaret C Lunn-Halbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.